FR

Astrazeneca Plc Ordinary Shares(AZN)

Description

une entreprise pharmaceutique qui développe des médicaments innovants et des préparations pharmaceutiques

Key stats

Earnings

  1. IMFINZI APPROVED IN US FOR EARLY BLADDER CANCER
  2. US FDA DECISION DATE ON CAMIZESTRANT EXTENDED
  3. DATROWAY APPROVED IN US FOR 1L TRIPLE-NEGATIVE BC
  4. ENHERTU RECOMMENDED IN EU FOR HER2+ SOLID TUMOURS